Follow
Maha Farhat
Maha Farhat
Associate Professor Harvard Medical School
Verified email at partners.org - Homepage
Title
Cited by
Cited by
Year
False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?
M Farhat, C Greenaway, M Pai, D Menzies
The International Journal of Tuberculosis and Lung Disease 10 (11), 1192-1204, 2006
9542006
A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis
CJ Karvellas, MR Farhat, I Sajjad, SS Mogensen, AA Leung, R Wald, ...
Critical care 15, 1-10, 2011
5602011
Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis
MR Farhat, BJ Shapiro, KJ Kieser, R Sultana, KR Jacobson, TC Victor, ...
Nature genetics 45 (10), 1183-1189, 2013
5092013
Interpreting Expression Data with Metabolic Flux Models: Predicting Mycobacterium tuberculosis Mycolic Acid Production
C Colijn, A Brandes, J Zucker, DS Lun, B Weiner, MR Farhat, TY Cheng, ...
PLoS computational biology 5 (8), e1000489, 2009
4642009
Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis
World Health Organization
World Health Organization, 2018
3752018
Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues
CJ Meehan, GA Goig, TA Kohl, L Verboven, A Dippenaar, M Ezewudo, ...
NATURE reviews microbiology 17 (9), 533-545, 2019
3372019
Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing
CRyPTIC Consortium and the 100,000 Genomes Project
New England Journal of Medicine 379 (15), 1403-1415, 2018
3362018
Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events
JE Lemieux, KJ Siddle, BM Shaw, C Loreth, SF Schaffner, ...
Science 371 (6529), eabe3261, 2021
295*2021
Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid …
S Kadura, N King, M Nakhoul, H Zhu, G Theron, CU Köser, M Farhat
Journal of Antimicrobial Chemotherapy 75 (8), 2031-2043, 2020
1622020
Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value
MR Farhat, R Sultana, O Iartchouk, S Bozeman, J Galagan, P Sisk, ...
American journal of respiratory and critical care medicine 194 (5), 621-630, 2016
1612016
Respiratory care: principles and practice
D Hess
Jones & Bartlett Learning, 2011
1572011
Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results
D Menzies, G Gardiner, M Farhat, C Greenaway, M Pai
The International Journal of Tuberculosis and Lung Disease 12 (5), 498-505, 2008
1562008
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
TM Walker, P Miotto, CU Köser, PW Fowler, J Knaggs, Z Iqbal, M Hunt, ...
The Lancet Microbe 3 (4), e265-e273, 2022
1502022
Gastrointestinal complications in critically ill patients with and without COVID-19
M El Moheb, L Naar, MA Christensen, C Kapoen, LR Maurer, M Farhat, ...
Jama 324 (18), 1899-1901, 2020
1432020
GWAS for quantitative resistance phenotypes in Mycobacterium tuberculosis reveals resistance genes and regulatory regions
MR Farhat, L Freschi, R Calderon, T Ioerger, M Snyder, CJ Meehan, ...
Nature communications 10 (1), 2128, 2019
1412019
Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe
M Hunt, P Bradley, SG Lapierre, S Heys, M Thomsit, MB Hall, KM Malone, ...
Wellcome open research 4, 2019
1242019
Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis
H Nebenzahl-Guimaraes, KR Jacobson, MR Farhat, MB Murray
Journal of antimicrobial chemotherapy 69 (2), 331-342, 2014
1022014
Beyond multidrug resistance: Leveraging rare variants with machine and statistical learning models in Mycobacterium tuberculosis resistance prediction
ML Chen, A Doddi, J Royer, L Freschi, M Schito, M Ezewudo, IS Kohane, ...
EBioMedicine 43, 356-369, 2019
101*2019
The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia
MI Gröschel, CJ Meehan, I Barilar, M Diricks, A Gonzaga, M Steglich, ...
Nature communications 11 (1), 2044, 2020
1002020
Population structure, biogeography and transmissibility of Mycobacterium tuberculosis
L Freschi, R Vargas Jr, A Husain, SMM Kamal, A Skrahina, S Tahseen, ...
Nature communications 12 (1), 6099, 2021
872021
The system can't perform the operation now. Try again later.
Articles 1–20